Drugmaker GlaxoSmithKline's $3 billion national settlement for health care fraud is enriching North Carolina's coffers by $31.8 million.
N.C. Attorney General Roy Cooper announced the state's share of the settlement, which included $2 billion in civil penalties and $1 billion in criminal fines, on Thursday. GSK is based in the United Kingdom and has its U.S. headquarters in Research Triangle Park.
Nearly $3.9 million will go to the state's public schools, with the remainder earmarked for Medicaid.
"Wrongdoing by drug companies and health care providers wastes taxpayers' money, deprives needy patients of care and inflates medical costs for all of us," Cooper said in a prepared statement. "We're continuing our crackdown on fraud and abuse in our health care system."
GSK's settlement resolved allegations that it improperly marketed 10 drugs. It also pleaded guilty to promoting the popular antidepressants Paxil and Wellbutrin for unapproved uses.
The settlement, which was approved by a federal judge in July, was the largest ever involving a pharmaceutical company.